The Open Discovery Innovation Network (ODIN) is a five-year project at Aarhus University from 2024-2029. The Novo Nordisk Foundation (NNF) awarded ODIN 180 M DKK to establish the network, facilitate co-creation of novel research projects and provide funding for the academic component of joint initiatives between academia and industrial partners from the pharma and biotech industries.
ODIN’s open approach aims to provide a substrate and a catalyst for innovation: ODIN projects must be equal collaborations between academia and industry on the earliest stages of drug discovery and they must address real industrial research needs. ODIN projects must generate the building blocks necessary for developing new innovative therapeutics and diagnostics downstream - and they must share their data and results openly with the public to accelerate innovation.
Watch the video to the right for a short introduction to ODIN is and why you should join us.
Below, you will find links to the most relevant information on ODIN.
The Open Discovery Innovation Network (ODIN) is a five-year project at Aarhus University from 2024-2029. The Novo Nordisk Foundation (NNF) awarded ODIN 180 M DKK to establish the network, facilitate co-creation of novel research projects and provide funding for the academic component of joint initiatives between academia and industrial partners from the pharma and biotech industries.
ODIN’s open approach aims to provide a substrate and a catalyst for innovation: ODIN projects must be equal collaborations between academia and industry on the earliest stages of drug discovery and they must address real industrial research needs. ODIN projects must generate the building blocks necessary for developing new innovative therapeutics and diagnostics downstream - and they must share their data and results openly with the public to accelerate innovation.
Watch the video below for a short introduction to what ODIN is and why you should join us.
We unite bright minds from industry and academia to jointly create need-driven clinical research projects - and pave the way for innovative new treatments and diagnostics. We fund the best project ideas through competitive funding calls. Although companies cannot receive funding, it is free of charge to join.
The platform is sponsored by the Novo Nordisk Foundation with 180 million DKK from 2024-2029.
You are welcome to contact us if you have questions or comments. Reach out to odin@au.dk or find the Secretariat's direct email addresses under contacts.
Although the platform spans five Danish universities, we're based in Aarhus. Our office is located at Aarhus University, Ny Munkegade 120, blg 1521-214.
